Venetoclax combined with three-day multi-frequency decitabine (DEC3-VEN) in elder or intensive chemotherapy ineligible patients with newly diagnosed acute myeloid leukemia
维奈托克联合三天多频次地西他滨(DEC3-VEN)用于老年或不适合接受强化化疗的新诊断急性髓系白血病患者
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-024-01189-2
Suo, Xiaohui; Ma, Xiaojun; Zheng, Fang; Wang, Dongmei; Bai, Guanchen; Zhao, Liyun; Han, Zhongjing; Lv, Xin; Zhang, Congcong; Wang, Ju; Tuo, Kangxin; Meng, Zhen; Liu, Shan; Gao, Sifeng; Zhang, Jilei; Jiao, Zongjiu; Song, Jiaojie; Li, Ling; Lu, Xinxiao; Yuan, Linyu; Liu, Kaiqi; Zhao, Xingli; Mi, Yingchang